Position in ZNTL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$112,092
-$68,684 QoQ
Shares Held
23,112
-70.1% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 114 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. ZNTL ranks #245 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in ZNTL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,092 | 23,112 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $180,776 | 77,255 | Shares | Defined | 2026-05-11 | |
| 2025-09-30 | $1,368 | 906 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $22,557 | 19,447 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $64,625 | 40,646 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $137,867 | 45,501 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $160,764 | 43,686 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $179,656 | 43,926 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $4,051,691 | 257,087 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,210,657 | 145,918 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,709,211 | 85,205 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $2,409,330 | 85,407 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $3,245,965 | 188,719 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $2,052,949 | 101,934 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $3,656,532 | 168,815 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,676,884 | 130,850 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,450,824 | 31,444 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $5,183,474 | 61,664 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $2,254,696 | 33,834 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $4,073,256 | 76,565 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,574,121 | 82,372 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $624,317 | 12,020 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $18,469 | 565 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $67,516 | 1,406 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||